Annual FCF
-$15.37 M
-$4.13 M-36.70%
December 31, 2023
Summary
- As of February 8, 2025, EPRX annual free cash flow is -$15.37 million, with the most recent change of -$4.13 million (-36.70%) on December 31, 2023.
- During the last 3 years, EPRX annual FCF has fallen by -$15.07 million (-5000.40%).
- EPRX annual FCF is now -5000.40% below its all-time high of -$301.40 thousand, reached on December 1, 2020.
Performance
EPRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$10.23 M
-$2.51 M-32.49%
September 1, 2024
Summary
- As of February 8, 2025, EPRX quarterly free cash flow is -$10.23 million, with the most recent change of -$2.51 million (-32.49%) on September 1, 2024.
- Over the past year, EPRX quarterly FCF has dropped by -$2.51 million (-32.49%).
- EPRX quarterly FCF is now -2979.79% below its all-time high of $355.30 thousand, reached on March 1, 2020.
Performance
EPRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$30.03 M
-$4.28 M-16.61%
September 1, 2024
Summary
- As of February 8, 2025, EPRX TTM free cash flow is -$30.03 million, with the most recent change of -$4.28 million (-16.61%) on September 1, 2024.
- Over the past year, EPRX TTM FCF has dropped by -$4.28 million (-16.61%).
- EPRX TTM FCF is now -8552.32% below its all-time high of $355.30 thousand, reached on March 1, 2020.
Performance
EPRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EPRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.7% | -32.5% | -16.6% |
| 3 y3 years | -5000.4% | -264.9% | -154.0% |
| 5 y5 years | -135.4% | -2979.8% | -8552.3% |
EPRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.7% | at low | -264.9% | at low | -175.1% | at low |
| 5 y | 5-year | -5000.4% | at low | -2979.8% | at low | -8552.3% | at low |
| alltime | all time | -5000.4% | at low | -2979.8% | at low | -8552.3% | at low |
Eupraxia Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.23 M(+32.5%) | -$30.03 M(+16.6%) |
| Jun 2024 | - | -$7.72 M(+26.0%) | -$25.75 M(+15.4%) |
| Mar 2024 | - | -$6.13 M(+3.0%) | -$22.31 M(+7.5%) |
| Dec 2023 | -$15.37 M(+36.7%) | -$5.95 M(-0.1%) | -$20.76 M(+6.9%) |
| Sep 2023 | - | -$5.95 M(+39.2%) | -$19.41 M(+11.3%) |
| Jun 2023 | - | -$4.28 M(-6.5%) | -$17.45 M(+8.4%) |
| Mar 2023 | - | -$4.58 M(-0.6%) | -$16.09 M(+10.0%) |
| Dec 2022 | -$11.25 M | - | - |
| Dec 2022 | - | -$4.60 M(+15.5%) | -$14.63 M(+14.0%) |
| Sep 2022 | - | -$3.99 M(+36.4%) | -$12.83 M(+17.6%) |
| Jun 2022 | - | -$2.92 M(-6.2%) | -$10.91 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.12 M(+11.1%) | -$11.47 M(-3.0%) |
| Dec 2021 | -$12.02 M(+3889.0%) | -$2.80 M(+35.4%) | -$11.82 M(+29.7%) |
| Sep 2021 | - | -$2.07 M(-40.5%) | -$9.12 M(+24.9%) |
| Jun 2021 | - | -$3.48 M(+0.3%) | -$7.30 M(+76.3%) |
| Mar 2021 | - | -$3.47 M(+3424.7%) | -$4.14 M(+1207.3%) |
| Dec 2020 | -$301.40 K(-92.3%) | -$98.40 K(-61.6%) | -$316.70 K(+45.1%) |
| Sep 2020 | - | -$256.20 K(-19.3%) | -$218.30 K(-676.0%) |
| Jun 2020 | - | -$317.40 K(-189.3%) | $37.90 K(-89.3%) |
| Mar 2020 | - | $355.30 K | $355.30 K |
| Dec 2019 | -$3.90 M(-40.2%) | - | - |
| Dec 2018 | -$6.53 M(+50.8%) | - | - |
| Dec 2017 | -$4.33 M | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual FCF year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly FCF year-on-year change?
- What is Eupraxia Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM FCF year-on-year change?
What is Eupraxia Pharmaceuticals annual free cash flow?
The current annual FCF of EPRX is -$15.37 M
What is the all time high annual FCF for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual free cash flow is -$301.40 K
What is Eupraxia Pharmaceuticals annual FCF year-on-year change?
Over the past year, EPRX annual free cash flow has changed by -$4.13 M (-36.70%)
What is Eupraxia Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of EPRX is -$10.23 M
What is the all time high quarterly FCF for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly free cash flow is $355.30 K
What is Eupraxia Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, EPRX quarterly free cash flow has changed by -$2.51 M (-32.49%)
What is Eupraxia Pharmaceuticals TTM free cash flow?
The current TTM FCF of EPRX is -$30.03 M
What is the all time high TTM FCF for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM free cash flow is $355.30 K
What is Eupraxia Pharmaceuticals TTM FCF year-on-year change?
Over the past year, EPRX TTM free cash flow has changed by -$4.28 M (-16.61%)